AI assistant
Sending…
SynAct Pharma — Major Shareholding Notification 2023
Dec 20, 2023
3114_iss_2023-12-20_4c7f1a76-1cea-461f-b0c6-99c605a46ffc.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer

Issuer SynAct Pharma AB
Holder
Nordnet AB (publ)
Instrument
| Instrument | Aktie SE0008241491 |
|---|---|
| Before the transaction | |
| Shares | Data not given* |
| Voting rights | Data not given* |
| Transaction | |
| Reason for major shareholding notification Share loan | |
| Date | 18/12/2023 |
| Limit for number of shares | 5 % |
| Limit for number of votes | 5 % |
| After the transaction | |
| Quantity | |
| Shares | 1,796,964 |
| Directly held voting rights | 0 |
| Indirectly held voting rights | 1,796,964 |
| Percentage | |
| Directly held shares | 5.05177 % |
| Directly held voting rights | 0 % |
| Indirectly held voting rights | 5.05177 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 5.05177 % | 1,796,964 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled | ||
| - Cash settled | 0.00281 % | 1,000 |
| Total | 5.05458 % | 1,797,964 |
Chain of controlling companies
| Voting rights % Voting rights Company | ||||
|---|---|---|---|---|
| 1,750,551 4.92129 | Nordnet Pensionsförsäkring AB | |||
| 0.13329 | Nordnet Livsforsikring AS | |||
| Group total holdings |
||||
| Voting rights | 1,797,964 | |||
| Percentage of voting rights 5.05458 | ||||
Published
20/12/2023 13:56
| Contact | ||
|---|---|---|
| Name | Felix Mandoki | |
| Phone | +46766110734 Email [email protected] |
*Source of information has chosen not to submit the data

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from SynAct Pharma
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Board/Management Information
2026
Apr 23
Governance Information
2026
Apr 23
Annual Report
2026
Apr 15
Major Shareholding Notification
2026
Apr 7
Share Issue/Capital Change
2026
Mar 31
Share Issue/Capital Change
2026
Mar 31
Major Shareholding Notification
2026
Mar 27
Capital/Financing Update
2026
Mar 2